Comparing Aerobic to Resistance Training in Recovery From Cancer

TriService Nursing Research Program1 site in 1 country58 target enrollmentNovember 2005

ConditionsNeoplasms

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Neoplasms
Sponsor: TriService Nursing Research Program
Enrollment: 58
Locations: 1
Primary Endpoint: quality of life
Status: Completed
Last Updated: 17 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to compare the health outcomes of a 12-week exercise program focused on aerobic training (using a treadmill) to a 12-week exercise program focused on resistance training (using Thera-Bands) in sedentary patients within 6 months of completing treatment for cancer.

Registry

clinicaltrials.gov

Start Date

November 2005

End Date

March 2008

Last Updated

17 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

TriService Nursing Research Program

Eligibility Criteria

Inclusion Criteria

•have a biopsy-proven cancer diagnosis
•be within six months of having completed chemotherapy or radiation therapy for treatment for cancer as determined by the primary physician
•be ambulatory but sedentary (i. e., has not followed an exercise regimen of a minimum of 3 times per week for at least 20 minutes each session over the previous six weeks)
•have an Eastern Cooperative Oncology Group (ECOG) Performance Status score of 0 asymptomatic) or 1 (symptomatic, fully ambulatory)
•be at least 18 years old
•be able to read and speak English
•have a medical statement from either the patient's primary care provider or the primary oncologist indicating that participation in the program is not medically contraindicated

Exclusion Criteria

•following an exercise regimen a minimum of 3 times per week for at least 20 minutes each session within the previous 6 weeks
•bone or joint destruction that could be aggravated with exercise
•severe cognitive impairment identified by either the patient's medical care provider or by the study team
•neuropathy-sensory common toxicity criteria (CTC) grade 3 (sensory loss or paresthesia interfering with activities of daily living) or grade 4 (permanent sensory loss that interferes with function) peripheral neuropathy